Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 9Unknown 7Terminated 4Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Leiomyoma 4Menorrhagia 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × ulipristal acetate × Clear all
NCT04004884 2024-05-20

LISA

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Terminated
30 enrolled

Leiomyoma

NCT02425878 2020-10-14

Ulipristal Acetate 10 mg and Asisted Reproduction

Instituto Valenciano de Infertilidad, IVI VALENCIA

Phase 3 Terminated
2 enrolled

Leiomyoma

NCT04132349 2020-04-13

Ulipristal Acetate in Symptomatic Uterine Fibroid

Mỹ Đức Hospital

Phase 4 Terminated
25 enrolled

Leiomyoma, Menorrhagia

NCT02825719 2020-04-09

Ulipristal Use in Chinese Population

Queen Mary Hospital, Hong Kong

Phase 4 Terminated
31 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡